MACROGENICS INC (MGNX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 40M 80M 120M Q3 '21: 15.7M Q4 '21: 14.1M Q1 '22: 11.1M Q2 '22: 26M Q3 '22: 41.7M Q4 '22: 73.1M Q1 '23: 24.5M Q2 '23: 13.1M Q3 '23: 10.4M Q4 '23: 10.7M Q1 '24: 9.1M Q2 '24: 10.8M Q3 '24: 110.7M Q4 '24: 19.4M Q1 '25: 13.2M Q2 '25: 6.9M Q3 '25: 72.8M Q4 '25: 41.2M Q1 '26: 20.8M Q2 '26: 32.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 40M 80M 120M Q1 '21: 16.9M Q2 '21: 30.7M Q3 '21: 14M Q4 '21: 13.2M Q1 '22: 11.1M Q2 '22: 25.8M Q3 '22: 38.7M Q4 '22: 73M Q1 '23: 24.4M Q2 '23: 12.9M Q3 '23: 10.3M Q4 '23: 10.6M Q1 '24: 8.8M Q2 '24: 10.6M Q3 '24: 110.5M Q4 '24: 19.1M Q1 '25: 13.2M Q2 '25: 6.9M Q3 '25: 72.8M Q4 '25: 41.2M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -53M Q4 '21: -58.2M Q1 '22: -66.6M Q2 '22: -41.8M Q3 '22: -25M Q4 '22: 12M Q1 '23: -38.4M Q2 '23: -45M Q3 '23: -35.5M Q4 '23: -49.4M Q1 '24: -53.8M Q2 '24: -58.2M Q3 '24: 54.2M Q4 '24: -52.8M Q1 '25: -42.6M Q2 '25: -43.2M Q3 '25: 18.6M Q4 '25: -5.6M Q1 '26: -33.4M Q2 '26: -13.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -52.9M Q4 '21: -58M Q1 '22: -66.4M Q2 '22: -41.3M Q3 '22: -24.8M Q4 '22: 12.8M Q1 '23: -38M Q2 '23: 57.5M Q3 '23: 17.6M Q4 '23: -46.1M Q1 '24: -52.2M Q2 '24: -55.7M Q3 '24: 56.3M Q4 '24: -15.4M Q1 '25: -41M Q2 '25: -36.3M Q3 '25: 16.8M Q4 '25: -14.2M Q1 '26: -36.8M Q2 '26: 19.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q1 '21: 17K Q2 '21: 22K Q3 '21: 1.7M Q4 '21: 947K Q1 '22: 48K Q2 '22: 180K Q3 '22: 3M Q4 '22: 116K Q1 '23: 113K Q2 '23: 258K Q3 '23: 85K Q4 '23: 163K Q1 '24: 270K Q2 '24: 176K Q3 '24: 168K Q4 '24: 233K Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -14.8M Q4 '21: -54.3M Q1 '22: -57.7M Q2 '22: -49.2M Q3 '22: -9.4M Q4 '22: 29.3M Q1 '23: -12.8M Q2 '23: -2.1M Q3 '23: -35.2M Q4 '23: -28M Q1 '24: -45.6M Q2 '24: -44.5M Q3 '24: 60.2M Q4 '24: -38.4M Q1 '25: -46.9M Q2 '25: -47M Q3 '25: -30.2M Q4 '25: 43M Q1 '26: -35.8M Q2 '26: -40.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -16.9M Q4 '21: -55.7M Q1 '22: -59.1M Q2 '22: -50.2M Q3 '22: -10.2M Q4 '22: 28.9M Q1 '23: -13.2M Q2 '23: -2.4M Q3 '23: -35.7M Q4 '23: -28.7M Q1 '24: -47.1M Q2 '24: -45.5M Q3 '24: 59.6M Q4 '24: -39M Q1 '25: -47.4M Q2 '25: -47.7M Q3 '25: -30.6M Q4 '25: 42.8M Q1 '26: -36.2M Q2 '26: -41.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '18: 42.2M Q2 '20: 50M Q3 '20: 54.5M Q1 '21: 57.2M Q2 '21: 60.1M Q3 '21: 61.2M Q1 '22: 61.3M Q2 '22: 61.4M Q3 '22: 61.5M Q1 '23: 61.8M Q2 '23: 62.3M Q3 '23: 62.2M Q1 '24: 62.3M Q2 '24: 62.7M Q3 '24: 62.9M Q1 '25: 63M Q2 '25: 63.1M Q3 '25: 63.3M Q1 '26: 63.4M Q2 '26: 63.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: -2.40 Q4 '21: -3.37 Q1 '22: -3.55 Q2 '22: -3.56 Q3 '22: -3.10 Q4 '22: -1.95 Q1 '23: -1.48 Q2 '23: 0.11 Q3 '23: 0.79 Q4 '23: -0.15 Q1 '24: -0.38 Q2 '24: -2.19 Q3 '24: -1.57 Q4 '24: -1.07 Q1 '25: -0.88 Q2 '25: -0.56 Q3 '25: -1.19 Q4 '25: -1.17 Q1 '26: -1.10 Q2 '26: -0.22 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.